IDH2 p.R172G
About
Gene context: IDH2
Biomarker Type: Somatic Variant
Present: True
Chromosome: 15
Start Position: 90631839
End Position: 90631839
Reference Allele: T
Alternate Allele: C
Cdna Change: c.514A>G
Protein Change: p.R172G
Variant Annotation: Missense
Exon: 4
Rsid: rs1057519906
Hgvsg: 15:g.90631839T>C
Legacy biomarker representation, assumes GRCh37 / hg19 genome build.
Mappings
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (1) | IDH2 p.R172G | Acute Myeloid Leukemia | Enasidenib | |
| EMA (1) FDA (1) | IDH2 p.R172G | Astrocytoma | Vorasidenib | |
| EMA (1) FDA (1) | IDH2 p.R172G | Oligodendroglioma | Vorasidenib |